AbbVie
ABBV
#33
Rank
$258.69 B
Marketcap
$146.28
Share price
-0.76%
Change (1 day)
6.86%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: $258.69 Billion

As of January 2023 AbbVie has a market cap of $258.69 Billion. This makes AbbVie the world's 33th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2023

End of year Market Cap

Year Market cap Change
2023$258.69 B-9.49%
2022$285.80 B19.4%
2021$239.37 B26.54%
2020$189.17 B44.47%
2019$130.94 B-3.95%
2018$136.33 B-11.7%
2017$154.39 B51.71%
2016$101.76 B6.7%
2015$95.37 B-8.42%
2014$104.14 B24.23%
2013$83.82 B55.32%
2012$53.97 B

End of Day market cap according to different sources

On Jan 29th, 2023 the market cap of AbbVie was reported to be:

$126.77 Billion
by Yahoo Finance
$126.87 Billion
by CompaniesMarketCap
$112.19 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$245.80 B-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$325.05 B 25.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$135.34 B-47.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.77 B-83.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$105.01 B-59.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$154.04 B-40.45%๐Ÿ‡บ๐Ÿ‡ธ USA
$204.73 B-20.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
$72.26 B-72.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
$10.40 B-95.98%๐Ÿ‡บ๐Ÿ‡ธ USA